Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 5, e3910

Comparison of Human Papillomavirus (HPV) Detection in Urine and Cervical Swab Samples Using the HPV GenoArray Diagnostic Assay


Comparison of Human Papillomavirus (HPV) Detection in Urine and Cervical Swab Samples Using the HPV GenoArray Diagnostic Assay

Pornjarim Nilyanimit et al. PeerJ.


Human papillomavirus (HPV) is the leading cause of cervical cancer. Urine-based HPV testing offers a simple and non-invasive method because of its increasing acceptance. A total of 164 pairs of cervical swab and urine samples from Thai women who underwent cervical cancer screening were used for HPV testing with HPV GenoArray Diagnostic Kits. The overall concordance percentage for HPV detection in the cervical swab and urine samples was 65.2%. The HPV genotypes most commonly detected were HPV16 and HPV18. An analysis of the urine samples and a second analysis of the cervical swab samples showed that the differences in the overall HPV detection rate between women with normal and abnormal cytology were not significant (p > 0.05). Urine samples processed with the GenoArray assay is an alternative for women who decline to undergo Pap smear even though it is not ideal as the first-line screening option.

Keywords: Cervical cancer; Genotyping; HPV; Urine.

Conflict of interest statement

The authors declare there are no competing interests.

Similar articles

See all similar articles

Cited by 2 PubMed Central articles


    1. Bernal S, Palomares JC, Artura A, Parra M, Cabezas JL, Robles A, Martín Mazuelos E. Comparison of urine and cervical samples for detecting human papillomavirus (HPV) with the Cobas 4800 HPV test. Journal of Clinical Virology. 2014;61:548–552. doi: 10.1016/j.jcv.2014.10.001. - DOI - PubMed
    1. Bernard HU, Chan SY, Manos MM, Ong CK, Villa LL, Delius H, Peyton CL, Bauer HM, Wheeler CM. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. Journal of Infectious Diseases. 1994;170:1077–1085. doi: 10.1093/infdis/170.5.1077. - DOI - PubMed
    1. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. WHO International Agency for Research on Cancer Monograph Working Group. A review of human carcinogens–Part B: biological agents. The Lancet Oncology. 2009;10:321–322. doi: 10.1016/S1470-2045(09)70096-8. - DOI - PubMed
    1. Brinkman JA, Rahmani MZ, Jones WE, Chaturvedi AK, Hagensee ME. Optimization of PCR based detection of human papillomavirus DNA from urine specimens. Journal of Clinical Virology. 2004;29:230–240. doi: 10.1016/S1386-6532(03)00157-4. - DOI - PubMed
    1. Castle PE, Gravitt PE, Solomon D, Wheeler CM, Schiffman M. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. Journal of Clinical Microbiology. 2008;46:109–117. doi: 10.1128/JCM.01667-07. - DOI - PMC - PubMed

Grant support

This work was supported by the National Research Council of Thailand, the Research Chair Grant from NSTDA, the Center of Excellence in Clinical Virology (GCE 59-009-30-005) and King Chulalongkorn University, the Centenary Academic Development Project (CU56-HR01), the Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530093), Office of Higher Education Commission (NRU 59-002-HR) and Dutsadi Piphat Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

LinkOut - more resources